Aberdeen Group plc

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
ProQR Therapeutics NV 13G
PRQR · N71542109
6.3% 7/29/2026
Event 6/30/2026
Eloxx Pharmaceuticals Inc 13G
ELOX · 29014R103
9.9% 7/27/2026
Event 6/30/2026
uniQure N.V. 13G/A
QURE · N90064101
4.5% 7/20/2026
Event 6/30/2026
Codexis, Inc. 13G/A
CDXS · 192005106
7.5% 7/20/2026
Event 6/30/2026
Immunic, Inc. 13G/A
IMUX · 4525EP200
6.1% 7/16/2026
Event 6/30/2026
Sera Prognostics, Inc. 13G/A
SERA · 81749D107
7.2% 7/15/2026
Event 6/30/2026
Equillium, Inc. 13G
EQ · 29446K106
5.3% 5/7/2026
Event 4/1/2026
Quoin Pharmaceuticals, Ltd. 13G/A
QNRX · 74907L409
4.2% 4/29/2026
Event 4/1/2026
Perceptive Capital Solutions Corp 13G
PCSC · G70077105
6.5% 4/28/2026
Event 4/1/2026
InspireMD, Inc. 13G/A
NSPR · 45779A846
7.5% 2/2/2026
Event 12/31/2025
Immunic, Inc. 13G/A
IMUX · 4525EP101
6.9% 2/2/2026
Event 12/31/2025
Tectonic Therapeutic, Inc. 13G
TECX · 878972108
6.1% 1/29/2026
Event 12/31/2025
Precision Biosciences Inc 13G
DTIL · 74019P207
8.9% 1/27/2026
Event 12/31/2025
Corbus Pharmaceuticals Holdings, Inc. 13G
CRBP · 21833P301
7.5% 1/16/2026
Event 12/31/2025